04 Dec 2017

Calls for stronger partnership between public, private healthcare providers

The Ministry of Health is looking for more opportunities for public and private healthcare providers to work together as Singapore’s healthcare needs are set to grow. This will allow the sector to pool its limited resources and leverage on the different healthcare providers’ capabilities, said Senior Minister of State for Health

0
13 Nov 2017

Seven Bridges Leads Public-Private Partnership To Develop New Data Ecosystem For NIH

Seven Bridges today announced that it has been selected by the National Institutes of Health (NIH) to support the NIH Data Commons Pilot Phase. As the only corporate service provider leading a pilot, Seven Bridges will build upon its expertise delivering the NCI Cancer Genomics Cloud to advance NIH’s vision

0
07 Nov 2017

Two Mount Sinai Institutes to Join $215 Million Public-Private Partnership to Increase Patients’ Immunotherapy Success

The Tisch Cancer Institute and the Precision Immunology Institute at Mount Sinai Health System are part of a $215 million public-private Cancer Moonshot research collaboration launched by the National Institutes of Health and 11 leading pharmaceutical companies. “We are at the critical juncture of really understanding why patients respond or

0
07 Nov 2017

Seven Bridges Leads Public-Private Partnership to Develop New Data Ecosystem for NIH

Consortium will build cloud-based data resources, tools, and interoperable standards, giving researchers simultaneous access to biomedical datasets from across the National Institutes of Health  Seven Bridges, the leading biomedical data analysis company, today announced that it has been selected by the National Institutes of Health (NIH) to support the NIH

0
17 Oct 2017

NIH launches $215M public-private partnership to support Cancer Moonshot

The National Institutes of Health has launched a five-year, $215 million public-private partnership with 11 biopharmaceutical vendors to accelerate development of new immunotherapy treatments in support of the Cancer Moonshot initiative. The Partnership for Accelerating Cancer Therapies (PACT), which will be managed by the Foundation for the National Institutes of

0
13 Oct 2017

NIH launches $215m partnership for cancer immunotherapy strategies

The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot…. The National Institutes of Health (NIH) and 11 leading biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT), a five-year public-private research collaboration totalling

0
18 Sep 2017

Government hospitals makeover under Public Private Partnership mode

Health Minister Kamineni Srinivas said that the state government is contemplating to hand over eight government hospitals to corporate hospitals if they come forward. Speaking to the media here on Saturday, Kamineni stated the government wants to develop infrastructure and improve medical services at district headquarters hospitals under the Public

0
11 Sep 2017

Public-private partnership gives lifeline to diabetes patients

Living with a health condition that constantly threatens your life for more than 36 years is no walk in the park. For Jane Muthoni, 44, tonsillitis at the age of eight was just another normal childhood ailment. She never imagined it could be an early sign of a condition she

0
31 Aug 2017

Philips India to increase PPP healthcare centres

Philips India on Tuesday said it is set to increase to 36 the number of public-private partnership (PPP) healthcare centres across the states of Haryana and Jharkhand by early 2019. According to the company, at present there were 10 operational PPP centres across Haryana and seven in Jharkhand. There were

0
01 Aug 2017

Antabio Wins $2.8 Million P3 Grant to Keep Developing Drug-Resistant Infection Therapy

A U.S. government-backed initiative against drug-resistant bacteria has awarded Antabio $2.8 million to continue developing treatments for Pseudomonas, the most common infection in cystic fibrosis (CF). The grant came from a public-private partnership known as CARB-X, which stands for Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator. CARB-X, formed in July 2016,

0